Savara Secures $150M Non-Dilutive Capital for MOLBREEVI Launch
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy HTGC?
Source: Newsfilter
- Loan Agreement Amendment: Savara amended its loan agreement with Hercules Capital to access an additional $75 million upon FDA approval of MOLBREEVI, thereby strengthening its liquidity and financial stability.
- Increased Capital Availability: With the addition of the $75 million royalty financing, Savara will have approximately $150 million in non-dilutive capital to support the launch of MOLBREEVI, ensuring a competitive edge in the biopharmaceutical market.
- Market Potential Assessment: A U.S. claims analysis by Savara revealed that the autoimmune pulmonary alveolar proteinosis market is 50% larger than previously estimated, providing a robust foundation for MOLBREEVI's commercialization and expected sales growth.
- Regulatory Application Progress: Savara resubmitted the Biologics License Application for MOLBREEVI in December 2025, and if granted Priority Review, FDA approval could be achieved by Q3 2026, further accelerating the product launch timeline.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HTGC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HTGC
Wall Street analysts forecast HTGC stock price to rise
7 Analyst Rating
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 15.960
Low
18.00
Averages
20.04
High
24.00
Current: 15.960
Low
18.00
Averages
20.04
High
24.00
About HTGC
Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Notice: Rosen Law Firm reminds investors who purchased Hercules Capital securities between May 1, 2025, and February 27, 2026, that they must apply to be lead plaintiff by May 19, 2026, to represent other investors in the class action lawsuit.
- Fee Arrangement: Investors participating in the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, which reduces financial barriers and encourages broader participation in the litigation.
- Lawsuit Background: The lawsuit alleges that Hercules Capital made false statements and misleading omissions regarding its portfolio valuation and loan origination processes, resulting in investor losses when the truth emerged, potentially damaging the company's reputation and future financing capabilities.
- Law Firm's Strength: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and effectiveness in handling such cases.
See More
- Lawsuit Background: Hercules Capital is facing a class action lawsuit alleging it misled investors between May 1, 2025, and February 27, 2026, regarding its investment sourcing and valuation processes, potentially leading to significant investor losses.
- Key Allegations: Hunterbrook Media's report claims that Hercules' deal sourcing merely replicates information from Google Ventures, raising serious questions about the transparency and accuracy of its portfolio valuations, which could impact the company's net asset value (NAV).
- Market Reaction: Following the release of Hunterbrook's findings, Hercules shares plummeted nearly 8% on February 27, 2026, indicating a severe loss of investor confidence and concerns over the company's financial health.
- Legal Implications: Hagens Berman is investigating whether Hercules violated federal securities laws, urging affected investors to file claims, suggesting that this case could have profound implications for Hercules' future operations and reputation.
See More
- Lawsuit Background: DJS Law Group alerts investors about a class action lawsuit against Hercules Capital for violations of §§10(b) and 20(a) of the Securities Exchange Act, covering shares purchased from May 1, 2025, to February 27, 2026.
- False Statement Allegations: The complaint alleges that Hercules overstated its due diligence in loan origination and portfolio valuation, rendering its public statements false and materially misleading throughout the class period, which has severely impacted investor confidence.
- Investor Participation: Shareholders who suffered losses are encouraged to contact DJS Law Group to participate in the lawsuit, with the note that appointment as lead plaintiff is not required to partake in any recovery, thus providing more opportunities for investor involvement.
- Legal Team Expertise: DJS Law Group focuses on enhancing investor returns through balanced counseling and aggressive advocacy, specializing in securities class actions and corporate governance litigation, ensuring that clients' litigation claims are treated as valuable assets deserving of respect and results.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Hercules Capital securities between May 1, 2025, and February 27, 2026, that they must apply to be lead plaintiff by May 19, 2026, to participate in the class action, as failure to do so will result in loss of representation.
- Lawsuit Background: The lawsuit alleges that Hercules Capital overstated its due diligence in deal sourcing and loan origination, leading to investor losses when the true information was disclosed, indicating significant misstatements in the company's financial reporting that could impact its market reputation.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, demonstrating its expertise and successful track record, which investors should consider when selecting legal counsel.
- Investor Rights Protection: Investors can obtain more information through Rosen Law Firm's website or by phone to join the class action without any upfront fees, ensuring their rights to potential compensation are protected.
See More
- Class Action Reminder: The Schall Law Firm alerts investors that Hercules Capital is facing a class action lawsuit for violations of securities laws, concerning trades made between May 1, 2025, and February 27, 2026, with a deadline for participation set for May 19, 2026.
- False Statement Allegations: The complaint alleges that Hercules Capital failed to conduct proper due diligence during the loan origination process and overstated its portfolio valuation process, leading to significant investor losses once the truth was revealed.
- Investor Damages: As Hercules Capital's public statements were found to be false and misleading, investors suffered substantial financial losses when the market learned the truth, highlighting serious deficiencies in the company's disclosure practices.
- Legal Consultation Opportunity: The Schall Law Firm offers free legal consultations and encourages affected investors to reach out to discuss their rights, demonstrating the firm's commitment to protecting shareholder interests.
See More
- Litigation Investigation: Faruqi & Faruqi, LLP is investigating potential securities fraud claims against Hercules Capital, urging investors to apply by May 19, 2026, to serve as lead plaintiffs in a class action to protect their legal rights.
- False Statement Allegations: The lawsuit alleges that Hercules Capital and its executives violated federal securities laws by overstating due diligence in deal sourcing and loan origination, misleading investors about the company's financial health.
- Stock Price Decline: On February 27, 2026, Hercules Capital's stock price fell by 7.9% to close at $14.21 per share in response to these allegations, reflecting market concerns over the company's financial transparency.
- Lack of Internal Audit: Reports indicate that Hercules's valuation team consists of only four members with insufficient review mechanisms, potentially leading to significant underreporting of software debt, further impacting investor confidence and the company's reputation.
See More











